Literature DB >> 25939753

Bmi1 is required for the initiation of pancreatic cancer through an Ink4a-independent mechanism.

Filip Bednar1, Heather K Schofield2, Meredith A Collins3, Wei Yan4, Yaqing Zhang1, Nikhil Shyam5, Jaime A Eberle6, Luciana L Almada7, Kenneth P Olive6, Nabeel Bardeesy8, Martin E Fernandez-Zapico7, Daisuke Nakada9, Diane M Simeone10, Sean J Morrison11, Marina Pasca di Magliano12.   

Abstract

Epigenetic dysregulation is involved in the initiation and progression of many epithelial cancers. BMI1, a component of the polycomb protein family, plays a key role in these processes by controlling the histone ubiquitination and long-term repression of multiple genomic loci. BMI1 has previously been implicated in pancreatic homeostasis and the function of pancreatic cancer stem cells. However, no work has yet addressed its role in the early stages of pancreatic cancer development. Here, we show that BMI1 is required for the initiation of murine pancreatic neoplasia using a novel conditional knockout of Bmi1 in combination with a Kras(G12D)-driven pancreatic cancer mouse model. We also demonstrate that the requirement for Bmi1 in pancreatic carcinogenesis is independent of the Ink4a/Arf locus and at least partially mediated by dysregulation of reactive oxygen species. Our data provide new evidence of the importance of this epigenetic regulator in the genesis of pancreatic cancer.
© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25939753      PMCID: PMC4566095          DOI: 10.1093/carcin/bgv058

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  38 in total

1.  Pancreatic cancer in mice and man: the Penn Workshop 2004.

Authors:  Ralph H Hruban; Anil K Rustgi; Teresa A Brentnall; Margaret A Tempero; Christopher V Wright; David A Tuveson
Journal:  Cancer Res       Date:  2006-01-01       Impact factor: 12.701

Review 2.  Polycomb silencers control cell fate, development and cancer.

Authors:  Anke Sparmann; Maarten van Lohuizen
Journal:  Nat Rev Cancer       Date:  2006-11       Impact factor: 60.716

Review 3.  Genome regulation by polycomb and trithorax proteins.

Authors:  Bernd Schuettengruber; Daniel Chourrout; Michel Vervoort; Benjamin Leblanc; Giacomo Cavalli
Journal:  Cell       Date:  2007-02-23       Impact factor: 41.582

4.  Ink4a and Arf differentially affect cell proliferation and neural stem cell self-renewal in Bmi1-deficient mice.

Authors:  Sophia W M Bruggeman; Merel E Valk-Lingbeek; Petra P M van der Stoop; Jacqueline J L Jacobs; Karin Kieboom; Ellen Tanger; Danielle Hulsman; Carly Leung; Yvan Arsenijevic; Silvia Marino; Maarten van Lohuizen
Journal:  Genes Dev       Date:  2005-06-15       Impact factor: 11.361

5.  Dysregulated expression of stem cell factor Bmi1 in precancerous lesions of the gastrointestinal tract.

Authors:  Keisuke Tateishi; Miki Ohta; Fumihiko Kanai; Bayasi Guleng; Yasuo Tanaka; Yoshinari Asaoka; Motohisa Tada; Motoko Seto; Amarsanaa Jazag; Lin Lianjie; Makoto Okamoto; Hiroyuki Isayama; Minoru Tada; Haruhiko Yoshida; Takao Kawabe; Masao Omata
Journal:  Clin Cancer Res       Date:  2006-12-01       Impact factor: 12.531

6.  Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice.

Authors:  Sunil R Hingorani; Lifu Wang; Asha S Multani; Chelsea Combs; Therese B Deramaudt; Ralph H Hruban; Anil K Rustgi; Sandy Chang; David A Tuveson
Journal:  Cancer Cell       Date:  2005-05       Impact factor: 31.743

7.  Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse.

Authors:  Nabeel Bardeesy; Andrew J Aguirre; Gerald C Chu; Kuang-Hung Cheng; Lyle V Lopez; Aram F Hezel; Bin Feng; Cameron Brennan; Ralph Weissleder; Umar Mahmood; Douglas Hanahan; Mark S Redston; Lynda Chin; Ronald A Depinho
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-03       Impact factor: 11.205

8.  The transcription factor GLI1 modulates the inflammatory response during pancreatic tissue remodeling.

Authors:  Esha Mathew; Meredith A Collins; Maite G Fernandez-Barrena; Alexander M Holtz; Wei Yan; James O Hogan; Zachary Tata; Benjamin L Allen; Martin E Fernandez-Zapico; Marina Pasca di Magliano
Journal:  J Biol Chem       Date:  2014-08-07       Impact factor: 5.157

9.  Bmi1 controls tumor development in an Ink4a/Arf-independent manner in a mouse model for glioma.

Authors:  Sophia W M Bruggeman; Danielle Hulsman; Ellen Tanger; Tessa Buckle; Marleen Blom; John Zevenhoven; Olaf van Tellingen; Maarten van Lohuizen
Journal:  Cancer Cell       Date:  2007-10       Impact factor: 31.743

10.  Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice.

Authors:  Carmen Guerra; Alberto J Schuhmacher; Marta Cañamero; Paul J Grippo; Lena Verdaguer; Lucía Pérez-Gallego; Pierre Dubus; Eric P Sandgren; Mariano Barbacid
Journal:  Cancer Cell       Date:  2007-03       Impact factor: 31.743

View more
  13 in total

Review 1.  Genetically Engineered Mouse Models of K-Ras-Driven Lung and Pancreatic Tumors: Validation of Therapeutic Targets.

Authors:  Matthias Drosten; Carmen Guerra; Mariano Barbacid
Journal:  Cold Spring Harb Perspect Med       Date:  2018-05-01       Impact factor: 6.915

2.  Redox-dependent BMI1 activity drives in vivo adult cardiac progenitor cell differentiation.

Authors:  Diego Herrero; María Tomé; Susana Cañón; Francisco M Cruz; Rosa María Carmona; Encarna Fuster; Enrique Roche; Antonio Bernad
Journal:  Cell Death Differ       Date:  2018-01-11       Impact factor: 15.828

3.  mTORC2 Signaling Drives the Development and Progression of Pancreatic Cancer.

Authors:  David R Driscoll; Saadia A Karim; Makoto Sano; David M Gay; Wright Jacob; Jun Yu; Yusuke Mizukami; Aarthi Gopinathan; Duncan I Jodrell; T R Jeffry Evans; Nabeel Bardeesy; Michael N Hall; Brian J Quattrochi; David S Klimstra; Simon T Barry; Owen J Sansom; Brian C Lewis; Jennifer P Morton
Journal:  Cancer Res       Date:  2016-10-06       Impact factor: 12.701

4.  Bmi1 combines with oncogenic KRAS to induce malignant transformation of human pancreatic duct cells in vitro.

Authors:  Shao-Jie Chen; Yin-Ting Chen; Lin-Juan Zeng; Qiu-Bo Zhang; Guo-da Lian; Jia-Jia Li; Ke-Ge Yang; Chu-Mei Huang; Ya-Qing Li; Zhong-Hua Chu; Kai-Hong Huang
Journal:  Tumour Biol       Date:  2016-03-08

Review 5.  GEMMs as preclinical models for testing pancreatic cancer therapies.

Authors:  Aarthi Gopinathan; Jennifer P Morton; Duncan I Jodrell; Owen J Sansom
Journal:  Dis Model Mech       Date:  2015-10-01       Impact factor: 5.758

Review 6.  BMI1: A Biomarker of Hematologic Malignancies.

Authors:  Anagh A Sahasrabuddhe
Journal:  Biomark Cancer       Date:  2016-05-05

Review 7.  Pancreatic Cancer, A Mis-interpreter of the Epigenetic Language.

Authors:  Eriko Iguchi; Stephanie L Safgren; David L Marks; Rachel L Olson; Martin E Fernandez-Zapico
Journal:  Yale J Biol Med       Date:  2016-12-23

Review 8.  Alterations of Epigenetic Regulators in Pancreatic Cancer and Their Clinical Implications.

Authors:  Brittany R Silverman; Jiaqi Shi
Journal:  Int J Mol Sci       Date:  2016-12-19       Impact factor: 5.923

Review 9.  A Novel Aspect of Tumorigenesis-BMI1 Functions in Regulating DNA Damage Response.

Authors:  Xiaozeng Lin; Diane Ojo; Fengxiang Wei; Nicholas Wong; Yan Gu; Damu Tang
Journal:  Biomolecules       Date:  2015-12-01

10.  Inactivation of the Euchromatic Histone-Lysine N-Methyltransferase 2 Pathway in Pancreatic Epithelial Cells Antagonizes Cancer Initiation and Pancreatitis-Associated Promotion by Altering Growth and Immune Gene Expression Networks.

Authors:  Guillermo Urrutia; Thiago Milech de Assuncao; Angela J Mathison; Ann Salmonson; Romica Kerketta; Atefeh Zeighami; Timothy J Stodola; Volkan Adsay; Burcin Pehlivanoglu; Michael B Dwinell; Michael T Zimmermann; Juan L Iovanna; Raul Urrutia; Gwen Lomberk
Journal:  Front Cell Dev Biol       Date:  2021-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.